Posts filed under: Respiratory Devices

ResMed recently announced new European research from Price Waterhouse Coopers (PwC), revealing that patients with sleep apnea who use ResMed’s myAir have greater adherence to CPAP (continuous positive airway pressure) therapy than those who don’t....
Continue Reading →
The anesthesia, respiratory and sleep management market in the U.S. is expected to increase to reach nearly $5.5 billion by 2023; the market is largely influenced by insurance policies, especially when it comes to durable devices governed under the durable...
Continue Reading →
A recent study by the American Association for the Advancement of Science showed several infants with life-threatening breathing problems are doing better thanks to printable biomaterial airway implants....
Continue Reading →
This trend is resulting in increased sales of lower-end automatic ventilators in the automatic infant resuscitators and hybrid ventilator categories....
Continue Reading →
FDA warned the use of this recalled product could cause serious health risks, including delayed patient treatment, breathing difficulties, and death....
Continue Reading →
  The market for portable oxygen concentrators continues to grow at double digit rates, with the share of ambulatory oxygen therapy patients on portable oxygen concentrators increasing steadily. The overall oxygen therapy market is broken into 6 types of devices:...
Continue Reading →
The U.S. anesthesia, respiratory and sleep-management device market will reach approximately $4 billion by 2017. Market growth will be driven by high sales of anesthesia information management systems (AIMS), which work to automate data collection in the anesthesia department, streamline...
Continue Reading →
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link